These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9313057

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of lower respiratory tract infections in the elderly].
    Komarova VP, Belousov IuB, Sokolov AV, Tishchenkova IF, Efremenkova OV.
    Antibiot Khimioter; 1997; 42(12):19-24. PubMed ID: 9480649
    [Abstract] [Full Text] [Related]

  • 8. [Clinical studies on ciprofloxacin in chronic respiratory tract infection].
    Yoshida M, Watanabe K, Tamaru N, Ishibashi T, Takamoto M, Yamada H, Katoh O, Yamaguchi T, Ando M, Matsumoto M.
    Jpn J Antibiot; 1991 May; 44(5):506-14. PubMed ID: 1880930
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and microbiological evaluation of pefloxacin in lower respiratory tract infections.
    Tatsis G, Tsoukalas G, Hatzinikolaou V, Boulbasakos G, Jordanoglou J.
    J Int Med Res; 1996 May; 24(6):478-81. PubMed ID: 8959532
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia.
    Pryka R, Kowalsky S, Haverstock D.
    Clin Ther; 1998 May; 20(1):141-55. PubMed ID: 9522111
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
    Fass RJ.
    Am J Med; 1987 Apr 27; 82(4A):202-7. PubMed ID: 3555037
    [Abstract] [Full Text] [Related]

  • 15. [Clinical evaluation of ciprofloxacin in pulmonary infections in the patients with chronic respiratory diseases].
    Kikuchi N, Kawashima T, Yamagishi F, Suzuki K, Yasuda J, Niijima Y, Mizutani F, Tabeta H.
    Jpn J Antibiot; 1991 Aug 27; 44(8):839-45. PubMed ID: 1920809
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW, Singh S, Johnson RH.
    J Antimicrob Chemother; 1999 Mar 27; 43 Suppl A():129-34. PubMed ID: 10225583
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ciprofloxacin therapy of respiratory tract infection with Pseudomonas aeruginosa.
    Haverkorn MJ.
    Eur J Clin Microbiol Infect Dis; 1988 Oct 27; 7(5):661-4. PubMed ID: 3143577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.